- News & Analysis
- Home
- Latest News
- Reports
- Podcasts
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Page 227
Beam hits series B with $135m
GV participated as a new investor, as genetic medicine developer Beam Therapeutics completed a round that followed $87m in series A funding last year.
Mar 7, 2019Wefox sniffs out $125m in series B
The Salesforce-backed online insurance platform is reportedly valued at nearly $1bn having raised funding from investors including CreditEase.
Mar 7, 2019Delhivery carries off $395m in series F round
SoftBank Vision Fund invested $350m in Delhivery at a $1.6bn valuation as part of a $395m round, and it now owns a 23.4% stake in the logistics services provider.
Mar 6, 2019Chime strikes a $200m chord with investors
Northwestern Mutual-backed digital bank Chime is now valued at $1.5bn following a series D round led by DST Global.
Mar 6, 2019Dream11 to realise another $100m funding dream
The Tencent-backed fantasy sports platform will reportedly be valued at between $1.3bn and $1.5bn following the rumoured $100m investment from Steadview Capital.
Mar 6, 2019Zomato gets $50m boost from Delivery Hero
Delivery Hero has confirmed a $50m investment in the food listings and ordering platform as part of a $105m second tranche of a round that now totals $315m.
Mar 5, 2019Ayana gets $330m recharge
The renewable energy project developer raised the cash in a round led by Eversource Capital, which is 50% owned by power producer Lightsource BP.
Mar 5, 2019Go-Jek accepts $100m from Astra
Astra International has committed $100m in series F capital to Go-Jek as part of an agreement to integrate the corporate’s fleet management system into Go-Jek’s vehicles.
Mar 4, 2019Analysis: DoorDash gets $400m order
Last-mile consumer goods delivery service provider DoorDash raised $400m, from SoftBank´s Vision Fund at a valuation of $7.1bn
Mar 4, 2019Maze finds its way to $191m
GV and Alexandria have taken part in a $191m round to launch Maze Therapeutics with scientific co-founders from multiple universities such as Harvard and Stanford.
Mar 1, 2019About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


